Transitions Optical announces members of its diversity advisory board for 2021-2022

Article

The panel aims to improve patient care amongst the fastest growing minority demographics within the eye care industry.

Transitions Optical’s diversity advisory board for 2022 will be made up of individuals in the largest and fastest-growing minority demographic groups in the United States.

Board members will work with the organization to develop programs that will improve the representation of minorities, particularly Black and Hispanic representation, within the eye care industry. The panel hopes to provide the best level of care to increasingly diverse patient populations.

Related: Is cultural competency a necessary optometric skill?

New and returning members of the Transitions Diversity Advisory Board include:

  • Lina Arango, ODfounder of LTA Vision and VICLE
  • Diana Canto-Sims, OD Buena Vista Optical and La Vida Eyewear
  • Brian Chou, OD ReVision Optometry
  • Mila Ferrerprograms manager, Beyond Type 1 and diabetes advocate
  • Darryl Glover, OD professional services special projects liaison and optometrist,MyEyeDr.
  • Essence Johnson, OD Parkland Hospital
  • Edwin Marshall, OD professor emeritus of optometry and formervice president for diversity, equity and multicultural affairs, Indiana University
  • Utenzi Miller owner, business manager, and optician at Elegant Eyes, Inc.
  • Janette Pepper, OD associate professor and coordinator of student diversity and inclusion at Southern College of Optometry
  • Devin J. Sasser, OD owner of Eye Clarity LLC
  • Vincent K. Young, MDchairman, division of ophthalmology, Albert Einstein Medical Center Philadelphia

The Transitions optical diversity advisory board is part of the organization's global sustainable development plan, which focuses on carbon footprint and circularity, world sight light education, and inclusion and ethics.

“With our Diversity Advisory Board we are building on the strong foundation Transitions Optical has around diversity and inclusion with actionable movement, focusing first on industry change via increased diversity among eyecare professionals,” said Patience Cook, North American marketing director, Transitions Optical. “It is our hope that along with our board members, we will be able to shape the face of the optical industry to better serve the needs of diverse patient bases.”

Related: How culture plays a role in patient communications

Recent Videos
Eye care practitioners reported moderate to high satisfaction with lifitegrast's ability to improve signs of dry eye, according to Melissa Barnett, OD, FAAO, FSLS.
Neda Gioia, OD, CNS, FOWNS, details the positive feedback gained so far from other optometrists that have been prescribing the NutriTears supplement to their dry eye patients.
Damaris Raymondi, OD, FAAO, highlighted the importance of building patient-doctor trust to learn about these practices, which can include non-traditional treatments like chamomile or manuka honey eye drops.
Noreen Shaikh, OD, Magdalena Stec, OD, FAAO, and Brenda Bohnsack, MD, PhD, emphasize that collaboration and communication are key to proper diagnosis and treatment.
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
A. Paul Chous, MA, OD, FAAO, details a presentation on this year's updates on diabetes given at this year's Academy meeting
© 2024 MJH Life Sciences

All rights reserved.